Quarterly Result30 May 2026, 10:21 pm
ANG Lifesciences: FY26 Revenue ₹9,160.45 Lacs
AI Summary
ANG Lifesciences India Ltd. announced audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results on May 30, 2026, following a review by the Audit Committee. The company's revenue from operations for the year ended March 31, 2026, stood at ₹9,160.45 lakhs compared to ₹8,991.01 lakhs in the previous year. The company reported a profit after tax of ₹110.25 lakhs for the quarter ended March 31, 2026.
Key Highlights
- ANG Lifesciences approved audited financial results for FY26.
- FY26 revenue from operations reached ₹9,160.45 lakhs.
- Q4 FY26 profit after tax was ₹110.25 lakhs.
- Board meeting was held on May 30, 2026, to approve the results.
Price Impact
More from ANG